(Q43873886)

27 November 2017

title

PET studies of 18F-memantine in healthy volunteers (English)

1 reference

27 November 2017

Ametamey SM

1

1 reference

27 November 2017

Bruehlmeier M

2

1 reference

27 November 2017

Kneifel S

3

1 reference

27 November 2017

Kokic M

4

1 reference

27 November 2017

Honer M

5

1 reference

27 November 2017

Arigoni M

6

1 reference

27 November 2017

Buck A

7

1 reference

27 November 2017

Burger C

8

1 reference

27 November 2017

Samnick S

9

1 reference

27 November 2017

Quack G

10

1 reference

27 November 2017

Schubiger PA

11

1 reference

27 November 2017

publication date

1 February 2002

1 reference

Nuclear Medicine and Biology

27 November 2017

published in

1 reference

27 November 2017

volume

29

1 reference

27 November 2017

issue

2

1 reference

27 November 2017

page(s)

227-231

1 reference

A new look at the statistical model identification

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900293-1

7 January 2021

Fluorine-18 radiolabelling, biodistribution studies and preliminary PET evaluation of a new memantine derivative for imaging the NMDA receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900293-1

7 January 2021

PET studies of [18F]methyl-MK-801, a potential NMDA receptor complex radioligand

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900293-1

7 January 2021

Different binding affinities of NMDA receptor channel blockers in various brain regions—Indication of NMDA receptor heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900293-1

7 January 2021

Glutamate neurotoxicity and diseases of the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900293-1

7 January 2021

Selective reduction of quisqualate (AMPA) receptors in Alzheimer cerebellum

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900293-1

7 January 2021

Effects of temporal sampling, glucose metabolic rates, and disruptions of the blood-brain barrier on the FDG model with and without a vascular compartment: studies in human brain tumors with PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900293-1

7 January 2021

Glycine potentiates the NMDA response in cultured mouse brain neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900293-1

7 January 2021

Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900293-1

7 January 2021

Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900293-1

7 January 2021

A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900293-1

7 January 2021

Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900293-1

7 January 2021

First SPET images of glutamate (NMDA) receptor activation in vivo in cerebral ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900293-1

7 January 2021

Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan).

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900293-1

7 January 2021

Anticonvulsant activity of the NMDA antagonists, D(-)4-(3-phosphonopropyl) piperazine-2-carboxylic acid (D-CPP) and D(-)(E)-4-(3-phosphonoprop-2-enyl) piperazine-2-carboxylic acid (D-CPPene) in a rodent and a primate model of reflex epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900293-1

7 January 2021

Electrophysiological study, biodistribution in mice, and preliminary PET evaluation in a rhesus monkey of 1-amino-3-[18F]fluoromethyl-5-methyl-adamantane (18F-MEM): a potential radioligand for mapping the NMDA-receptor complex

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900293-1

7 January 2021

NMDA receptor losses in putamen from patients with Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900293-1

7 January 2021

10.1016/S0969-8051(01)00293-1

Identifiers

DOI

1 reference

27 November 2017

1 reference